I got a full panel before starting and a repeat at three months, and the second one is more useful than the first purely because I now have something to compare against.
Post reference ranges alongside numbers when you share them. Units differ by country — glucose and lipids especially — and half the confusion in these threads is unit mismatch rather than disagreement.
The bit I cannot resolve on my own is how often to repeat it, because quarterly seems to be the convention and I cannot find the reasoning.
I have searched first, so if this is covered somewhere point me at it and I will read it.
This one has a reasonably settled answer, so here it is. The single most useful discipline is bringing the whole panel to a clinician rather than one flagged value. One out-of-range result in isolation generates anxiety and unnecessary tests; the same result next to the trend and the rest of the panel usually generates a shrug.
If somebody has the primary source to hand I would rather cite it than paraphrase it.
DanielChem_CHI said:The single most useful discipline is bringing the whole panel to a clinician rather than one flagged value.
No disagreement with DanielChem_CHI. One condition attached. One addition: if the lab changes analytical platform between your draws, the comparison breaks and nobody tells you. It is worth asking when a value moves inexplicably.
PeptideDetective — Independent Peptide Analytics
Community-driven peptide testing and vendor rating platform. Transparent results. Unbiased analysis. Trusted by thousands.
View ResultsMikeFit_NJ said:I got a full panel before starting and a repeat at three months, and the second one is more useful than the first purely because I now have something…
Same position here, arrived at the long way round. Quarterly for the first year is convention rather than evidence, and it is defensible for a simple reason: it is roughly the interval over which HbA1c becomes informative again, since it reflects about three months of glycaemia. After the first year, and once doses are stable, annual is reasonable unless something specific is being followed.
Clinical perspective, offered as context rather than as advice.
Shot day Thursday report relevant to baseline bloodwork:
Week 16. Currently on 5mg. Down 22 lbs from starting weight of 234 lbs.
This week's observations: Energy levels excellent, zero nausea.
Labs due next week — looking forward to seeing the metabolic panel. I'll post results in the Lab Results section when they come in.